Cargando...
Biologics in inflammatory bowel disease: what are the data?
BACKGROUND: Over the last decade, biologics have gained an important place for the treatment of moderate to severe inflammatory bowel disease (IBD), and many randomized control trials have evaluated their efficacy. AIM: The goal of this review is to analyze the results of these trials and to highlig...
Gardado en:
| Publicado en: | United European Gastroenterol J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625751/ https://ncbi.nlm.nih.gov/pubmed/26535119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615590302 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|